Interview with Bradley Paddock, CEO of CeQur In June 2019, Bradley Paddock joined CeQur®, as Chief Executive Officer. We spoke to Bradley to hear about his first 6 months in the company and discuss the up-coming U.S. launch of its three-day insulin delivery device for type 2 diabetes. [...]
Interview with Dennis Wahr, President and CEO, Nuvaira In 2019, Nuvaira was accepted into a unique program developed by the Haute Autorité de Santé (HAS, the French health technology assessment agency), the Forfait Innovation Program. We spoke to Nuvaira’s CEO Dennis Wahr to learn more. Can you summarise [...]
Endeavour Vision accelerates investments in Switzerland and the US – an interview with AGEFI Endeavour Vision Founding Partners Damien Tappy and Bernard Vogel spoke to AGEFI about the next fund and the firm’s investment approach. Read the article from AGEFI here Medtech: Endeavour Vision accélère ses investissements en [...]
Interview with Rob Barmann, Senior Investment Director at Endeavour Vision Previously Vice President, Corporate Business Development at Boston Scientific. Rob, you joined Endeavour Vision after 15 years working at Boston Scientific, can you summarise your role there? My job was to assess and execute business development transactions including acquisitions, [...]
Interview with Kevin Hykes, President & CEO at Relievant Can you tell us a bit about Relievant Medsystems and the Intracept® Procedure? Relievant is a venture-backed medical device company founded in 2006, based in Minneapolis and Sunnydale, California with around 45 employees. Our focus is currently shifting from [...]
CeQur appoints Bradley Paddock Chief Executive Officer Medical Device Veteran Has 23-Year Record of Successful Commercial and Organizational Leadership MARLBOROUGH, Mass., June 5, 2019 — CeQur® announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech successes, [...]
Interview with Chris Owens, CEO & President at Gynesonics, Inc What is Gynesonics about? How are you changing the standard of care in uterine fibroids? Gynesonics is focused on advancing women’s health by developing uterus-preserving, incision free, transcervical technology. Currently, we are focused on the treatment of symptomatic [...]
Endeavour Vision aims to be among the world leaders – an interview with AGEFI The medtech specialization of VC Geneva Endeavour Vision, among the leading Europeans, is reinforced with the launch of a new fund dedicated end 2018. Interview with Damien Tappy, president and co-founder. La stratégie d’Endeavour [...]
How Endeavour became a reference in medtech – an interview with Bilan Endeavour Vision launched Europe's largest medical technology fund (medtech) in 2016 from Geneva. A second should follow in the coming months. An interview with its president and co-founder, Damien Tappy. Endeavour Vision a lancé le plus [...]
Endeavour Vision invests in surgical bone repairs specialist Medartis Endeavour Vision invested in Medartis. Located in Basel, Switzerland, the company develops, manufactures and distributes medical internal fixation devices and surgical instruments offered in system solutions for small bone fractures focusing on the extremities. Medartis was founded in 1997 [...]